lirafugratinib   Click here for help

GtoPdb Ligand ID: 12370

Synonyms: example 343 [WO2020231990A1] | RLY-4008 | RLY4008
PDB Ligand
Compound class: Synthetic organic
Comment: Lirafugratinib (RLY-4008) is a tyrosine kinase inhibitor with antineoplastic activity. It is one of the chemical compounds that are claimed in patent WO2020231990A1 as FGFR inhibitors [2]. Shubbiah et al. disclosed RLY-4008 as a selective FGFR2 inhibitor [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 7
Topological polar surface area 120.84
Molecular weight 509.2
XLogP 4.75
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Cc1ccnc(n1)Oc1ccc(cc1F)c1c(c2ccc(cc2)NC(=O)C(=C)C)n(c2c1c(N)ncn2)C
Isomeric SMILES Cc1nc(ncc1)Oc1c(cc(cc1)c1c(n(c2ncnc(c12)N)C)c1ccc(cc1)NC(=O)C(=C)C)F
InChI InChI=1S/C28H24FN7O2/c1-15(2)27(37)35-19-8-5-17(6-9-19)24-22(23-25(30)32-14-33-26(23)36(24)4)18-7-10-21(20(29)13-18)38-28-31-12-11-16(3)34-28/h5-14H,1H2,2-4H3,(H,35,37)(H2,30,32,33)
InChI Key XOQVZSSDIQQUGO-UHFFFAOYSA-N
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
fibroblast growth factor receptor 2 Hs Inhibitor Inhibition >7.0 pIC50 - 2
pIC50 >7.0 (IC50 <1x10-7 M) [2]
Description: Determiend in a FGFR2 biochemical caliper assay